Atyr Pharma Inc (NASDAQ:ATYR) currently has a daily average trading volume of 1.50M but it saw 1852763 shares traded in last market. With a market cap of 338.22M USD, the company’s current market price of $3.80 came rising about 1.33 while comparing to the previous closing price of $3.75. In past 52 weeks, the stock remained buoying in the range of price level as high as $4.66 and as low as $1.42.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Leerink Partners which initiated the stock as “Outperform” in its note to investors issued on February 18, 2025, recommending a price target of $16 for it. Wells Fargo also issued its recommendations for the stock as it initiated the price target for the stock is $17.
Over the week, ATYR’s stock price is moving 26.67% up while it is 7.95% when we observe its performance for the past one month. Year-to-date it is 4.97% up and over the past year, the stock is showing an upside performance of 83.57%.
The company is expected to be releasing its next quarterly report in June, for which analysts forecasted an EPS of -0.18 while estimate for next year EPS is -0.66. In next quarter, company is expected to be making quarterly sales of $1.2M as analysts are expecting the sales for current fiscal year at $2M and seeing the company making $27.67M in sales next year.
Currently, Atyr Pharma Inc’s total number of outstanding shares is 89.00M with 2.23% of that held by the insiders while 69.57% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -73.10% and return on equity (ROE) at -79.51%. Stock’s beta reads 0.81. Stock has a price to book (P/B) ratio of 4.51. Its return on asset (ROA) is -60.25% on average.
